健帆生物科技集团股份有限公司, established in 1989, specializes in the research, production, and sales of biological materials and high-tech medical devices. It focuses on blood purification products and is listed on the A-share Growth Enterprise Market.

Jafron Biomedical Co.,Ltd. engages in the research, development, production, and marketing of biological materials and medical devices in China. It offers solutions for kidney, liver, critical, and rheumatism diseases, as well as poisoning; adsorption products and blood purification machines; and other products, such as single use arteriovenous puncture, hemodialysis online dry powder bags/cylinders, disinfectants, hemodialysis concentrates, and medical adsorbable suture with needles. The company offers its products in Germany, Italy, Turkey, Thailand, Vietnam, the Philippines, South Africa, Kenya, Chile, Peru, and the United Arab Emirates. Jafron Biomedical Co.,Ltd. was founded in 1989 and is based in Zhuhai, China.

3005

COM:JAFRON

健帆生物科技集团股份有限公司

Last Close

31.85

07/11 07:04

Market Cap

22.44B

Beta: -

Volume Today

13.65M

Avg: -

locale

market

industry

website

ipo date

peer of

Metrics